SYDNEY, Australia & SAN DIEGO--(BUSINESS WIRE)--Nov. 8, 2005--Avantogen (ASX:ACU) today announced the acceptance of a scientific paper entitled, “Synergistic Effects of Immune Agonists on Efficacy of Vaccines” for the 20th Annual Meeting of the International Society for Biological Therapy of Cancer. The meeting will be held November 11 - 13, 2005, at the Hilton Alexandria Mark Center, Alexandria, VA, and focuses on the prevailing issues in immunology and biological therapy of cancer. Dante Marciani, Ph.D., Avantogen’s Chief Scientist, Immunotherapy, will present the Poster to the attending scientists. The abstract of the presentation will be published in the November/December 2005 issue of the Journal of Immunotherapy.
